Immunic Inc. – Filings and Transcripts

NASDAQ: IMUX
Share price (7/2/26): $14.80
Market cap (7/2/26): $202 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration – amended

Registration of securities for employees

Shelf registration

Exempt offering of securities

Registration of securities for employees

Ownership Filter

Skerjanec Simona

Rudick Richard Alan

News Filter

Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

To Present Additional Phase 2 CALLIPER Trial Data for Vidofludimus Calcium at the CMSC Annual Meeting 2026, Reinforcing Its Potential in Progressive Multiple Sclerosis

Appoints Distinguished Biopharmaceutical Executive Erik Lundgren as Chief Executive Officer

Appoints Seasoned Biopharmaceutical Executive Michael W. Bonney as Chair of the Board of Directors

Reports First Quarter 2026 Financial Results and Provides Corporate Update

Proxies Filter

Definitive proxy

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC